Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and -independent fatty liver.
Level 5 - mechanism / opinion, no new human data
In vitro laboratory mechanistic study without human clinical outcome data.
PubMed 23035112 · doi:10.1074/jbc.M112.399899
What was done
In vitro mechanistic experiments in hepatocytes investigated the role of uric acid and fructose metabolism in hepatic steatosis. The study examined the pathway from fructose phosphorylation by fructokinase to purine degradation, AMP deaminase activation, uric acid generation, mitochondrial oxidative stress, Krebs cycle aconitase inhibition, and subsequent activation of ATP citrate lyase and fatty-acid synthase.
What was found
The abstract reports no numerical values, effect sizes, or statistical metrics. Qualitatively, exposing hepatocytes to uric acid caused mitochondrial dysfunction and increased de novo lipogenesis. Fructose metabolism produced uric acid and mitochondrial oxidants, which inhibited aconitase and stimulated lipogenic enzymes; blocking uric acid prevented fructose-induced lipogenesis.
Why it matters
This study outlines a biochemical mechanism establishing uric acid as a direct contributor to de novo lipogenesis and hepatic steatosis rather than merely an inert bystander marker.
Limits
Findings are limited to preclinical in vitro cellular models without in vivo or human clinical validation. The abstract omits sample sizes, replicate numbers, cell types, and quantitative effect measurements.
Cited by
- supports Initial fructose metabolism consumes intracellular ATP, causing intracellular phosphate and ATP levels to fall while suppressing AMP-activated protein kinase (AMPK) activation.
- supports Mitochondrial oxidative stress induced by uric acid inhibits aconitase in the Krebs cycle, stimulating citrate accumulation, fat production, and insulin resistance while blocking beta-oxidation of fatty acids.